74,25 €
0,92 % vorgestern
L&S, 24. Oktober, 22:54 Uhr
ISIN
US7751331015
Symbol
ROG
Berichte

Rogers Corp. Aktie News

Neutral
Seeking Alpha
2 Tage alt
Roche Holding AG (OTCQX:RHHBY) Q3 2025 Sales Call October 23, 2025 8:00 AM EDT Company Participants Thomas Schinecker - Group Chief Executive Officer Alan Hippe - Chief Financial Officer Teresa Graham - Chief Executive Officer of Roche Pharmaceuticals Matthew Sause - Chief Executive Officer Bruno Eschli - Head of Investor Relations Conference Call Participants Richard Vosser - JPMorgan Chase & ...
Neutral
Seeking Alpha
4 Tage alt
Roche Holding AG (OTCQX:RHHBY) Shareholder/Analyst Call October 21, 2025 11:00 AM EDT Company Participants Bruno Eschli - Head of Investor Relations Nilesh Mehta - Global Franchise Head - Ophthalmology Chris Brittain - Global Head of Ophthalmology Product Development & VP Conference Call Participants Nisha Acharya César Briceño Michael Leuchten - Jefferies LLC, Research Division Peter Verdult -...
Neutral
Business Wire
9 Tage alt
CHANDLER, Ariz.--(BUSINESS WIRE)--Rogers Corporation (NYSE: ROG) (the “Company”) today announced that Peter Wallace, Chair of the Board of Directors (the “Board”), has informed the Board of his decision not to stand for re-election at the Company's 2026 Annual Meeting of Shareholders. In anticipation of this transition, the Board has elected Armand Lauzon, an existing member of the Board since ...
Neutral
Business Wire
10 Tage alt
CHANDLER, Ariz.--(BUSINESS WIRE)--Rogers Corporation (NYSE:ROG) (“Rogers”) plans to announce third quarter 2025 results on October 29, 2025 after market close, which will be followed by a conference call at 5:00 pm ET. The call will be hosted by Ali El-Haj, Interim President and Chief Executive Officer, who will be joined by Laura Russell, Senior Vice President and Chief Financial Officer. A li...
Neutral
Seeking Alpha
etwa ein Monat alt
Roche Holding AG - Special Call Company Participants Bruno Eschli - Head of Investor Relations Teresa Graham - Chief Executive Officer of Roche Pharmaceuticals Levi Garraway - Executive VP, Head of Global Product Development & Chief Medical Officer Charles Fuchs - Global Head of Oncology & Hematology Drug Development - Genentech & Roche Hideki Garren Larry Tsai Chris Brittain - Global Head of O...
Neutral
WSJ
3 Monate alt
The activist investor agitated at the company in 2023 and struck a settlement deal.
Neutral
The Motley Fool
3 Monate alt
Rogers (ROG) Q2 Revenue Beats by 2%
Neutral
Seeking Alpha
3 Monate alt
Rogers Corporation (NYSE:ROG ) Q2 2025 Earnings Conference Call July 31, 2025 5:00 PM ET Company Participants Ali El-Haj - Interim President & Interim CEO Laura Russell - CFO, Senior VP & Treasurer Stephen Haymore - Director of Investor Relations Conference Call Participants Craig Andrew Ellis - B. Riley Securities, Inc., Research Division Daniel Joseph Moore - CJS Securities, Inc. Operator Goo...

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen